Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonists (Q40069794)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonists |
scientific article |
Statements
1 reference
Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonists (English)
1 reference
Frederick Wolfe
1 reference
Nancy Shadick
1 reference
Montserrat Vera-Llonch
1 reference
Elena Massarotti
1 reference
Rene Westhovens
1 reference
Oleg Sofrygin
1 reference
Ross Maclean
1 reference
Tracy Li
1 reference
Gerry Oster
1 reference
15 July 2008
1 reference
1 reference
35
1 reference
9
1 reference
1745-1753
1 reference
Identifiers
1 reference